Video head impulse in comparison to caloric testing in unilateral vestibular schwannoma

2016 ◽  
Vol 136 (11) ◽  
pp. 1110-1114 ◽  
Author(s):  
Isaac Tranter-Entwistle ◽  
Patrick Dawes ◽  
Cynthia L. Darlington ◽  
Paul F. Smith ◽  
Nicholas Cutfield
2019 ◽  
Vol 161 (2) ◽  
pp. 324-329 ◽  
Author(s):  
C. Scott Brown ◽  
Sarah B. Peskoe ◽  
Thomas Risoli ◽  
Douglas B. Garrison ◽  
David M. Kaylie

Objective To determine relationships between caloric testing (CT) and video head impulse testing (vHIT) among patients with unilateral vestibular schwannoma (VS). To describe the distribution of CT and vHIT measurements and assess associations with tumor size and self-perceived handicapping effects. Study Design Retrospective review. Setting Tertiary referral hospital. Subjects and Methods Subjects were adults with presumed unilateral VS between 2014 and 2017. Interventions were CT and vHIT. Primary outcomes were vHIT value (abnormal <0.8) and CT value (abnormal >25%). Secondary outcomes were tumor size and Dizziness Handicap Inventory scores. Results Fifty-one individuals had complete data for CT and vHIT. The odds of abnormal gain increases by 2.18 for every 10% increase in unilateral weakness on CT (range, 1.44-3.34; P < .001). A significant negative correlation between CT and gain exists ( rs = −0.64, P < .001). Odds of observing saccades increased by 2.68 for every 10% increase in unilateral weakness (range, 1.48-4.85; P = .001). This association was larger in magnitude for overt than covert saccades (odds ratios, 2.48 and 1.59, respectively). Tumor size was significantly associated with an increase in caloric weakness (β = 0.135, P < .001). With every 10-mm increase of tumor size, odds of abnormal gain on vHIT increased 4.13 (range, 1.46-11.66; P = .007). Mean Dizziness Handicap Inventory score was 19.7 (σ = 22), without association to caloric weakness, gain, or tumor size. Conclusion CT and vHIT both effectively assess vestibular function for patients with VS and correlate to tumor size. These findings are important as vHIT has a lower overall cost, improved patient tolerance, and demonstrated reliability.


2020 ◽  
Author(s):  
Eduardo Martin Sanz ◽  
Alba Larran ◽  
Angela Cuesta ◽  
Joaquin Yanes Diaz ◽  
Jonathan Esteban ◽  
...  

2008 ◽  
Vol 128 (11) ◽  
pp. 1215-1220 ◽  
Author(s):  
Meeli Hirvonen ◽  
Heikki Aalto ◽  
Timo Petteri Hirvonen

2019 ◽  
Vol 40 (4) ◽  
pp. 511-516 ◽  
Author(s):  
Felipe Constanzo ◽  
Bernardo Corrêa de Almeida Teixeira ◽  
Patricia Sens ◽  
Ricardo Ramina

2018 ◽  
Author(s):  
A Lundershausen ◽  
P Schendzielorz ◽  
M Bürklein ◽  
K Rak ◽  
R Hagen

Sign in / Sign up

Export Citation Format

Share Document